Retrophin, Inc. | Business Operations | Business Contracts

First Amendment to Master Manufacturing Supply Agreement, effective as of November 14, 2022, between the Company and STA Pharmaceutical Hong Kong Limited, a subsidiary of WuXi... (Filed With SEC on February 23, 2023)

Amendment No. 1 to the License and Collaboration Agreement, effective as of October 5, 2022, by and between Travere Therapeutics Switzerland GmbH (formerly known as Orphan... (Filed With SEC on February 23, 2023)

Commercial Supply Agreement, dated December 21, 2021, between the Company and Catalent Pharma Solutions, LLC (Filed With SEC on February 24, 2022)

License and Collaboration Agreement, dated September 15, 2021, by and among Orphan Technologies Limited and Vifor (International) Ltd., and, solely with respect to Article 15, the... (Filed With SEC on October 29, 2021)

Master Manufacturing Supply Agreement, dated September 30, 2020, between the Company and STA Pharmaceutical Hong Kong Limited, a subsidiary of WuKi AppTec (Filed With SEC on November 5, 2020)

Open Market Sales Agreement, dated February 24, 2020, by and between Retrophin, Inc. and Jefferies LLC (Filed With SEC on February 24, 2020)

Retrophin, Inc. (118) | Business Operations (6)